Serum Institute Of India
-
{
- All
- News
- Videos
-
Serum Institute And Oxford Partner For Bundibugyo Ebola Vaccine Clinical Trials
- Thursday June 4, 2026
- Health | Written by Debosmita Ghosh
Supported by funding from the Coalition for Epidemic Preparedness Innovations (CEPI), the collaboration aims to rapidly manufacture vaccine doses and begin clinical trials.
-
www.ndtv.com
-
"Not Humanly Possible To...": Adar Poonawalla On Work Hours vs Productivity
- Thursday January 23, 2025
- India News | Reported by Vishnu Som, Edited by Saikat Kumar Bose
Amid the nationwide debate on work-life balance after problematic remarks by some industry leaders, Adar Poonawalla, CEO of vaccine manufacturer Serum Institute, has said it is not humanly possible to be productive beyond a certain number of hours
-
www.ndtv.com
-
"Really Hate Mosquitoes": At Davos, Adar Poonawalla Explains Vaccine Plans To NDTV
- Wednesday January 22, 2025
- World News | Reported by Vishnu Som, Edited by Debanish Achom
Serum Institute of India CEO Adar Poonawalla spoke to NDTV on a range of issues, key among them the vaccine for malaria and other mosquito-borne diseases, on the sidelines of the World Economic Forum (WEF) meeting in Davos.
-
www.ndtv.com
-
Serum Institute's New "High Efficacy" Malaria Vaccine Rolls Out In Africa
- Monday July 15, 2024
- World News | Press Trust of India
A new "high efficacy" malaria vaccine co-developed by the Serum Institute of India (SII) and the University of Oxford was officially rolled out on Monday when Cote d'Ivoire in West Africa became the first country to begin administering R21/Matrix-M.
-
www.ndtv.com
-
Serum Institute Begins Shipments Of Malaria Vaccine 'R21/Matrix-M' To Africa
- Monday May 20, 2024
- India News | Press Trust of India
Vaccines manufacturer Serum Institute of India (SII) on Monday said it has started exports of 'R21/Matrix-M' malaria vaccine to Africa as part of the global fight against the disease.
-
www.ndtv.com
-
Couple Allege Daughter Died After Taking Covishield, To Sue AstraZeneca
- Friday May 3, 2024
- India News | NDTV News Desk
The parents of a young woman who died allegedly after being given Covishield are planning to sue the world's largest vaccine maker and the British pharma giant that had developed the vaccine during the Covid pandemic.
-
www.ndtv.com
-
Vaccine Maker Adar Poonawalla To Buy Mansion In London's Mayfair. It Costs...
- Tuesday December 12, 2023
- India News | NDTV News Desk
Billionaire CEO of Serum Institute of India, Adar Poonawalla, has sealed a deal to buy a multi-million-pound mansion in London's Mayfair, the Financial Times reported.
-
www.ndtv.com
-
Oxford University, Serum Institute Deliver 'High Efficacy' Malaria Vaccine
- Thursday April 13, 2023
- India News | Press Trust of India
A University of Oxford developed and Serum Institute of India (SII) manufactured and scaled up "high efficacy" malaria vaccine has been licensed for use in Ghana by Africa's Food and Drugs Authority, the university announced here on Thursday.
-
www.ndtv.com
-
Serum Institute Restarts Manufacturing Of COVID-19 Vaccine Covishield
- Wednesday April 12, 2023
- India News | Press Trust of India
Serum Institute of India CEO Adar Poonawalla on Wednesday said the company has restarted manufacturing of COVID-19 vaccine Covishield amid rising numbers of cases of the virus infection.
-
www.ndtv.com
-
Serum Institute Restarts Production Of Covishield Vaccine After Cases Rise
- Wednesday April 12, 2023
- India News | Press Trust of India
Serum Institute of India CEO Adar Poonawalla on Wednesday said the company has restarted manufacturing of COVID-19 vaccine Covishield amid rising numbers of cases of the virus infection.
-
www.ndtv.com
-
Serum Institute Seeks Inclusion Of Covovax On CoWIN As Booster Dose For Adults
- Monday April 3, 2023
- India News | Press Trust of India
The DCGI approved Covovax for restricted use in emergency situations in adults on December 28, 2021, in the 12-17 age group on March 9, 2022, and in the 7-11 age group on June 28, 2022, subject to certain conditions.
-
www.ndtv.com
-
Serum Institute's Cervical Cancer Vaccine To Hit Market This Month: Report
- Thursday February 9, 2023
- India News | Press Trust of India
The Serum Institute's made-in-India vaccine against cervical cancer, CERVAVAC, will be available in the market this month at an MRP of Rs 2,000 per vial of two doses, official sources said on Thursday.
-
www.ndtv.com
-
Serum Institute Seeks Inclusion Of Covid Jab 'Covovax' In CoWIN Portal
- Wednesday January 18, 2023
- India News | Press Trust of India
Serum Institute of India has written to the Union Health Ministry seeking the inclusion of its Covid vaccine Covovax in the CoWIN portal as a heterologous booster dose for adults, official sources said on Wednesday.
-
www.ndtv.com
-
Serum Institute To Provide 2 Crore Covishield Doses To Centre For Free
- Wednesday December 28, 2022
- India News | Press Trust of India
The Serum Institute of India has offered two crore doses of Covishield vaccine to the central government free of cost amid a rise in COVID-19 cases in some countries, official sources said today.
-
www.ndtv.com
-
Posing As Adar Poonawalla, Scammers Dupe Serum Institute Of Rs 1 Crore, 7 Arrested
- Saturday November 26, 2022
- India News | Asian News International
In a major breakthrough, the Pune Police said today that they have arrested seven accused in the cheating case in which Serum Institute of India (SII) was cheated of over Rs 1.01 crore.
-
www.ndtv.com
-
Serum Institute And Oxford Partner For Bundibugyo Ebola Vaccine Clinical Trials
- Thursday June 4, 2026
- Health | Written by Debosmita Ghosh
Supported by funding from the Coalition for Epidemic Preparedness Innovations (CEPI), the collaboration aims to rapidly manufacture vaccine doses and begin clinical trials.
-
www.ndtv.com
-
"Not Humanly Possible To...": Adar Poonawalla On Work Hours vs Productivity
- Thursday January 23, 2025
- India News | Reported by Vishnu Som, Edited by Saikat Kumar Bose
Amid the nationwide debate on work-life balance after problematic remarks by some industry leaders, Adar Poonawalla, CEO of vaccine manufacturer Serum Institute, has said it is not humanly possible to be productive beyond a certain number of hours
-
www.ndtv.com
-
"Really Hate Mosquitoes": At Davos, Adar Poonawalla Explains Vaccine Plans To NDTV
- Wednesday January 22, 2025
- World News | Reported by Vishnu Som, Edited by Debanish Achom
Serum Institute of India CEO Adar Poonawalla spoke to NDTV on a range of issues, key among them the vaccine for malaria and other mosquito-borne diseases, on the sidelines of the World Economic Forum (WEF) meeting in Davos.
-
www.ndtv.com
-
Serum Institute's New "High Efficacy" Malaria Vaccine Rolls Out In Africa
- Monday July 15, 2024
- World News | Press Trust of India
A new "high efficacy" malaria vaccine co-developed by the Serum Institute of India (SII) and the University of Oxford was officially rolled out on Monday when Cote d'Ivoire in West Africa became the first country to begin administering R21/Matrix-M.
-
www.ndtv.com
-
Serum Institute Begins Shipments Of Malaria Vaccine 'R21/Matrix-M' To Africa
- Monday May 20, 2024
- India News | Press Trust of India
Vaccines manufacturer Serum Institute of India (SII) on Monday said it has started exports of 'R21/Matrix-M' malaria vaccine to Africa as part of the global fight against the disease.
-
www.ndtv.com
-
Couple Allege Daughter Died After Taking Covishield, To Sue AstraZeneca
- Friday May 3, 2024
- India News | NDTV News Desk
The parents of a young woman who died allegedly after being given Covishield are planning to sue the world's largest vaccine maker and the British pharma giant that had developed the vaccine during the Covid pandemic.
-
www.ndtv.com
-
Vaccine Maker Adar Poonawalla To Buy Mansion In London's Mayfair. It Costs...
- Tuesday December 12, 2023
- India News | NDTV News Desk
Billionaire CEO of Serum Institute of India, Adar Poonawalla, has sealed a deal to buy a multi-million-pound mansion in London's Mayfair, the Financial Times reported.
-
www.ndtv.com
-
Oxford University, Serum Institute Deliver 'High Efficacy' Malaria Vaccine
- Thursday April 13, 2023
- India News | Press Trust of India
A University of Oxford developed and Serum Institute of India (SII) manufactured and scaled up "high efficacy" malaria vaccine has been licensed for use in Ghana by Africa's Food and Drugs Authority, the university announced here on Thursday.
-
www.ndtv.com
-
Serum Institute Restarts Manufacturing Of COVID-19 Vaccine Covishield
- Wednesday April 12, 2023
- India News | Press Trust of India
Serum Institute of India CEO Adar Poonawalla on Wednesday said the company has restarted manufacturing of COVID-19 vaccine Covishield amid rising numbers of cases of the virus infection.
-
www.ndtv.com
-
Serum Institute Restarts Production Of Covishield Vaccine After Cases Rise
- Wednesday April 12, 2023
- India News | Press Trust of India
Serum Institute of India CEO Adar Poonawalla on Wednesday said the company has restarted manufacturing of COVID-19 vaccine Covishield amid rising numbers of cases of the virus infection.
-
www.ndtv.com
-
Serum Institute Seeks Inclusion Of Covovax On CoWIN As Booster Dose For Adults
- Monday April 3, 2023
- India News | Press Trust of India
The DCGI approved Covovax for restricted use in emergency situations in adults on December 28, 2021, in the 12-17 age group on March 9, 2022, and in the 7-11 age group on June 28, 2022, subject to certain conditions.
-
www.ndtv.com
-
Serum Institute's Cervical Cancer Vaccine To Hit Market This Month: Report
- Thursday February 9, 2023
- India News | Press Trust of India
The Serum Institute's made-in-India vaccine against cervical cancer, CERVAVAC, will be available in the market this month at an MRP of Rs 2,000 per vial of two doses, official sources said on Thursday.
-
www.ndtv.com
-
Serum Institute Seeks Inclusion Of Covid Jab 'Covovax' In CoWIN Portal
- Wednesday January 18, 2023
- India News | Press Trust of India
Serum Institute of India has written to the Union Health Ministry seeking the inclusion of its Covid vaccine Covovax in the CoWIN portal as a heterologous booster dose for adults, official sources said on Wednesday.
-
www.ndtv.com
-
Serum Institute To Provide 2 Crore Covishield Doses To Centre For Free
- Wednesday December 28, 2022
- India News | Press Trust of India
The Serum Institute of India has offered two crore doses of Covishield vaccine to the central government free of cost amid a rise in COVID-19 cases in some countries, official sources said today.
-
www.ndtv.com
-
Posing As Adar Poonawalla, Scammers Dupe Serum Institute Of Rs 1 Crore, 7 Arrested
- Saturday November 26, 2022
- India News | Asian News International
In a major breakthrough, the Pune Police said today that they have arrested seven accused in the cheating case in which Serum Institute of India (SII) was cheated of over Rs 1.01 crore.
-
www.ndtv.com